SUPERSEDED Local Coverage Determination (LCD)

MolDX: Molecular Diagnostic Tests (MDT)

L35160

Expand All | Collapse All
Proposed LCD
Proposed LCDs are works in progress that are available on the Medicare Coverage Database site for public review. Proposed LCDs are not necessarily a reflection of the current policies or practices of the contractor.
Superseded
To see the currently-in-effect version of this document, go to the section.

Document Note

Note History

Contractor Information

LCD Information

Document Information

Source LCD ID
N/A
LCD ID
L35160
Original ICD-9 LCD ID
Not Applicable
LCD Title
MolDX: Molecular Diagnostic Tests (MDT)
Proposed LCD in Comment Period
N/A
Source Proposed LCD
N/A
Original Effective Date
For services performed on or after 10/01/2015
Revision Effective Date
For services performed on or after 11/01/2019
Revision Ending Date
N/A
Retirement Date
N/A
Notice Period Start Date
08/16/2015
Notice Period End Date
09/30/2015
AMA CPT / ADA CDT / AHA NUBC Copyright Statement

CPT codes, descriptions and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2023, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the American Hospital Association (AHA) copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

Issue

Issue Description
Issue - Explanation of Change Between Proposed LCD and Final LCD

CMS National Coverage Policy

Title XVIII of the Social Security Act (SSA) §1862(a)(1)(A), states that no Medicare payment shall be made for items or services that "are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of malformed body member."

Title XVIII of the Social Security Act (SSA) §(a)(1)(D), Investigational or Experimental.

45 CFR 162.1002 (A)(5).

Publication 100-08 PIM, Ch. 13, §13.1.3, Program Integrity Manual, “LCDs consist of only “reasonable and necessary” information.

 

Coverage Guidance

Coverage Indications, Limitations, and/or Medical Necessity

This coverage policy provides the following information:

• defines tests required to register for a unique identifier
• defines tests required to submit a complete technical assessment (TA) for coverage determination
• defines the payment rules applied to covered tests that are not reported with specific codes from a code set recognized in 45 CFR §162.1002(a)(5), and termed "HIPAA compliant code sets" throughout the remainder of this LCD
• lists specific covered tests that have completed the registration and TA process and meet Medicare’s reasonable and necessary criteria for coverage. 

Tests evaluated through the application process and/or technical assessment will be reviewed to answer the following questions:

• Is the test performed in the absence of clinical signs and symptoms of disease?
• Will the test results provide the clinician with information that will improve patient outcomes and/or change physician care and treatment of the patient?
• Will the test results confirm a diagnosis or known information?
• Is the test performed to determine risk for developing a disease or condition?
• Will risk assessment change management of the patient?
• Is there a diagnosis specific indication to perform the test?
• Is the test performed to measure the quality of a process or for Quality Control/Quality Assurance (QC/QA), i.e., a test to ensure a tissue specimen matches the patient?


MDT Policy Specific Definitions

MDT: Any test that involves the detection or identification of nucleic acid(s) (DNA/RNA), proteins, chromosomes, enzymes, cancer chemotherapy sensitivity and/or other metabolite(s). The test may or may not include multiple components. A MDT may consist of a single mutation analysis/identification, and/or may or may not rely upon an algorithm or other form of data evaluation/derivation.

Laboratory developed test (LDT): Any test developed by a laboratory developed without Food and Drug Administration (FDA) approval or clearance.

Applicable Tests/Assays

In addition to the MDT definition, this coverage policy applies to all tests that meet at least one of the following descriptions:
• All non-FDA approved/cleared laboratory developed tests (LDT)
• All modified FDA-approved/cleared kits/tests/assays
• All tests/assays billed with more than one code from a HIPAA compliant code set to identify the service, including combinations of method-based, serology-based, and anatomic pathology codes
• All tests that meet the first three bullets and are billed with a Not Otherwise Classified NOC code
 

Unique Test Identifier Requirement

Because the available language in the current HIPAA compliant code sets used to describe the pathology and laboratory categories and the tests included in those categories are not specific to the actual test results provided, all MDT services must include an identifier as additional claim documentation. Test providers must receive an identifier specific to the applicable test and submit the test assigned identifier with the claim for reimbursement. The assigned identifier will provide a crosswalk between the test’s associated detail information on file and the submitted claim detail line(s) required to adjudicate each test’s claim. The unique identifier limits the need to submit the required additional information about the test on each claim.


Technology Assessments (TA)

MolDX will review all new test/assay clinical information to determine if a test meets Medicare’s reasonable and necessary requirement. Labs must submit a comprehensive dossier on each new test/assay prior to claim submission. MolDX will only cover and reimburse tests that demonstrate analytical and clinical validity, and clinical utility at a level that meets the Medicare reasonable and necessary requirement.

Payment Rules

MolDX will reimburse:
• approved tests covered for dates of service consistent with the effective date of the coverage determination.

Covered Tests

Please refer to the Noridian website for specific coding and billing information for services addressed in MolDX.

Other tests/assays may be addressed by separate Noridian policy. In addition the CPT codes listed under Group 1 are addressed in the MolDX program. If a test is not linked below under Related Local Coverage Documents, it may be addressed under separate Noridian policy or it has not been approved for coverage as it has either not been vetted by the MolDx contractor or has been found to be considered statutorily excluded.


For additional MolDX Program information, go to the Noridian Medicare home page at noridianmedicare.com and select MolDX under the Policies Tab.

MolDX expects laboratory providers to follow test indications published by the developer.

Summary of Evidence

N/A

Analysis of Evidence (Rationale for Determination)

N/A

Proposed Process Information

Synopsis of Changes
Changes Fields Changed
N/A
Associated Information
Sources of Information
Bibliography
Open Meetings
Meeting Date Meeting States Meeting Information
N/A
Contractor Advisory Committee (CAC) Meetings
Meeting Date Meeting States Meeting Information
N/A
MAC Meeting Information URLs
N/A
Proposed LCD Posting Date
Comment Period Start Date
Comment Period End Date
Reason for Proposed LCD
Requestor Information
This request was MAC initiated.
Requestor Name Requestor Letter
N/A
Contact for Comments on Proposed LCD

Coding Information

Bill Type Codes

Code Description
N/A

Revenue Codes

Code Description
N/A

CPT/HCPCS Codes

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

ICD-10-CM Codes that Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

Additional ICD-10 Information

General Information

Associated Information

N/A

Sources of Information

Current Procedural Terminology® (CPT) American Medical Association. American Medical Association Press, ISBN9781603592178, 2011.

Bibliography

N/A

Revision History Information

Revision History Date Revision History Number Revision History Explanation Reasons for Change
11/01/2019 R14

Under CMS National Coverage Policy added regulation 45 CFR §162.1002 (a)(5).

Under Coverage Indications, Limitations and/or Medical Necessity changed the third bullet to read, “defines the payment rules applied to covered tests that are not reported with specific codes from a code set recognized in 45 CFR §162.1002 (a)(5), and termed “HIPAA compliant code sets” throughout the remainder of this LCD”.

Under Applicable Tests/Assays subheading changed verbiage under the third bullet to read, “All tests/assays billed with more than one code from a HIPAA compliant code set to identify the service, including combinations of method-based, serology-based, and anatomic pathology codes”.

Under Unique Test Identifier Requirement subheading changed verbiage in the first two sentences to read, “Because the available language in the current HIPAA compliant code sets used to describe the pathology and laboratory categories and the tests included in those categories are not specific to the actual test results provided, all MDT services must include an identifier as additional claim documentation. Test providers must receive an identifier specific to the applicable test and submit the test assigned identifier with the claim for reimbursement” and deleted the verbiage, “Laboratory providers who bill MDT services must register test services on the DEX Diagnostics Exchange”. Under Covered Tests subheading deleted the verbiage, “To obtain a unique identifier for a test and, to submit information for a technical assessment go to DEX Diagnostics Exchange https://app.dexzcodes.com/login”.


At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Provider Education/Guidance
11/01/2019 R13

11/01/2019:  This LCD is being revised in order to adhere to CMS requirements per Chapter 13, Section 13.5.1 of the Program Integrity Manual. There has been no change in coverage with this LCD revision.

Regulations regarding billing and coding were removed from the CMS National Coverage Policy section of this LCD and placed in the related Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) A57626 article.

At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Provider Education/Guidance
11/01/2019 R12

As required by CR 10901, all billing and coding information has been moved to the companion article, this article is linked to the LCD.

At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Revisions Due To Code Removal
11/01/2019 R11

Under CPT/HCPCS Codes Group 1: Codes added code range 0084U-0104U. This revision is due to the Q3 2019 CPT/HCPCS Code Update and is effective for dates of service on or after 7/1/2019. 0104U is deleted effective 10/1/2019.

At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Creation of Uniform LCDs With Other MAC Jurisdiction
  • Revisions Due To CPT/HCPCS Code Changes
01/01/2019 R10

01/23/2019 - Either the short and/or long code description was changed for the following code(s). Please Note: Depending on which descriptor was used, there may not be any changes to the code display in this document:
0008U descriptor was changed in Group 1
0011M descriptor was changed in Group 1

  • Creation of Uniform LCDs With Other MAC Jurisdiction
01/01/2019 R9

The following paragraph under Covered Tests has been clarified:

Other tests/assays may be addressed by separate Noridian policy. In addition the CPT codes listed under Group 1 are addressed in the MolDX program. If a test is not linked below under Related Local Coverage Documents, it may be addressed under separate Noridian policy or it has not been approved for coverage as it has either not been vetted by the MolDx contractor or has been found to be considered statutorily excluded.

  • Other (Clarification of paragraph requested by the MolDX contractor.)
01/01/2019 R8

Corrected typographical error in R7 revision history: CPT codes 71178, 71179, 71180 should be 81178, 81179 and 81180.

  • Typographical Error
01/01/2019 R7

The following updates were made as a result of the 2019 Annual HCPCS code update:

Deleted codes:0001M, 81211, 81213, 81214

Codes added to existing ranges: 81163, 81164, 81165, 81166, 81167, 81171, 81172, 81173, 81174, 81177, 71178, 71179, 71180, 81181, 81182, 81183, 81184, 81185, 81186, 81187, 81188, 81189, 81190, 81204, 81233, 81234, 81236, 81237, 81239, 81237, 81239, 81271, 81274, 81284, 81285, 81286, 81289, 81305 ,81306, 81312, 80320, 81329, 81333, 81336, 81337, 81343, 81344,81345, 81443, 81518,81596

Codes with descriptor changes: 0006U, 0012M, 0031U, 0032U, 81109, 81162, 81212, 81215, 81216, 81217, 81244, 81287, 81327, 81334

 

  • Creation of Uniform LCDs With Other MAC Jurisdiction
  • Revisions Due To CPT/HCPCS Code Changes
06/21/2018 R6

Removed: 88399, 89398, 87999, 88199, 88299

Added: 0001U, 0002U, 0003U, 0005U, 0006U, 0007U, 0008U, 0009U, 0010U, 0011U, 0012U, 0013U, 0014U, 0016U, 0017U, 0018U, 0019U, 0020U, 0021U, 0022U, 0023U, 0024U, 0025U, 0026U, 0027U, 0028U, 0029U, 0030U, 0031U, 0032U, 0033U, 0034U, 0035U, 0036U, 0037U, 0038U, 0039U, 0040U, 0041U, 0042U, 0043U, 0044U, 0011M, 0012M, 0013M, 81105-81112, 81120-81121, 86152-86153, 88120-88121.

  • Creation of Uniform LCDs With Other MAC Jurisdiction
  • Revisions Due To CPT/HCPCS Code Changes
01/01/2018 R5

Removed G0452, 88380, 88381 because they no longer require a DEX Z code identifier. Revised the link for technical assessment information.

03/29/2018: At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Creation of Uniform LCDs With Other MAC Jurisdiction
01/01/2018 R4

The following changes were made as a result of the Annual 2018 CPT/HCPCS code update:

81175, 81176, 81230, 81231, 81232, 81238, 81247, 81248, 81249, 81258, 81259, 81269, 81283, 81328, 81334, 81335, 81346, 81361, 81362, 81363, 81364, 81448, 81520, 81521, 81541 and 81551 were added to code range 81161 - 81599 in Group 1.

CPT codes are current as of the AMA CPT® 2018 Professional Edition, ISBN 978-1-62202-600-5, ISSN 0276-8283.

12/5/2017 At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Creation of Uniform LCDs With Other MAC Jurisdiction
  • Revisions Due To CPT/HCPCS Code Changes
01/01/2017 R3 2017 CPT Code Changes:
The following CPT/HCPCS codes were added to these code ranges:
81327 was added to code range 81161 - 81599 in Group 1
81413 was added to code range 81161 - 81599 in Group 1
81414 was added to code range 81161 - 81599 in Group 1
81422 was added to code range 81161 - 81599 in Group 1
81439 was added to code range 81161 - 81599 in Group 1
81539 was added to code range 81161 - 81599 in Group 1

Description was changed for the following CPT/HCPCS codes:
81402 descriptor was changed in Group 1, 81407 descriptor was changed in Group 1

CPT/HCPCS codes were deleted:
0010M, 81280, 81281 and 81282 was deleted from Group 1.
  • Revisions Due To CPT/HCPCS Code Changes
04/21/2016 R2 Replaced Palmetto GBA reference with MolDX, Under "Unique Test Identifier Requirement" - removed instruction to register services via Z-Code Identifier Application and Palmetto GBA Test Identifier (PTI) Application. Under "Payment Rules" - removed suspension of claims that omit Z-Code IDs. Under "Covered Tests" - updated the point of contact for McKesson and MolDX.) JEA LCD L36249 is retired and JEA contract numbers are added to the JEB LCD so that JEA and JEB have the same MCD LCD number.
  • Creation of Uniform LCDs With Other MAC Jurisdiction
10/01/2015 R1 This LCD is the final ICD-10 version of DL33541 Molecular Diagnostic Tests (MDT), which was initially introduced into draft in ICD-9 format and finalized in ICD-10 format.

  • Creation of Uniform LCDs Within a MAC Jurisdiction
  • Creation of Uniform LCDs With Other MAC Jurisdiction
N/A

Associated Documents

Attachments
N/A
Related National Coverage Documents
N/A
Public Versions
Updated On Effective Dates Status
05/03/2023 05/04/2023 - N/A Currently in Effect View
01/29/2020 11/01/2019 - 05/03/2023 Superseded View
01/23/2020 11/01/2019 - N/A Superseded You are here
12/04/2019 11/01/2019 - N/A Superseded View
10/17/2019 11/01/2019 - N/A Superseded View
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Keywords

  • 0002M
  • 0003M
  • 0004M
  • 0006M
  • 0007M
  • 0008M
  • 0009M
  • 0011M
  • 0012M
  • 0013M
  • 0001U
  • 0002U
  • 0003U
  • 0005U
  • 0006U
  • 0007U
  • 0008U
  • 0009U
  • 0010U
  • 0011U
  • 0012U
  • 0013U
  • 0014U
  • 0016U
  • 0017U
  • 0018U
  • 0019U
  • 0021U
  • 0022U
  • 0023U
  • 0024U
  • 0025U
  • 0026U
  • 0027U
  • 0029U
  • 0030U
  • 0031U
  • 0032U
  • 0033U
  • 0034U
  • 0035U
  • 0036U
  • 0037U
  • 0038U
  • 0039U
  • 0040U
  • 0041U
  • 0042U
  • 0043U
  • 0044U
  • 0070U
  • 81105
  • 81106
  • 81107
  • 81107
  • 81108,
  • 81109,
  • 81110
  • 81111
  • 81112
  • 81120
  • 88121
  • 81161
  • 81162
  • 81170
  • 81175
  • 81176
  • 81200
  • 81201
  • 81202
  • 81203
  • 81205
  • 81206
  • 81207
  • 81208
  • 81209
  • 81210
  • 81211
  • 81212
  • 81213
  • 81214
  • 81215
  • 81216
  • 81217
  • 81218
  • 81219
  • 81220
  • 81221
  • 81222
  • 81223
  • 81224
  • 81225
  • 81226
  • 81227
  • 81228
  • 81229
  • 81230
  • 81231
  • 81232
  • 81235
  • 81238
  • 81240
  • 81241
  • 81242
  • 81243
  • 81244
  • 81245
  • 81246
  • 81247
  • 81248
  • 81249
  • 81250
  • 81251
  • 81252
  • 81253
  • 81254
  • 81255
  • 81256
  • 81257
  • 81258
  • 81259
  • 81260
  • 81261
  • 81262
  • 81263
  • 81264
  • 81265
  • 81266
  • 81267
  • 81268
  • 81269
  • 81270
  • 81272
  • 81273
  • 81275
  • 81276
  • 81283
  • 81287
  • 81288
  • 81290
  • 81291
  • 81292
  • 81293
  • 81294
  • 81295
  • 81296
  • 81297
  • 81298
  • 81299
  • 81300
  • 81301
  • 81302

Read the LCD Disclaimer